Literature DB >> 18317340

Management of retinal detachment in Coats disease. Study of 15 cases.

Sarah Mrejen1, Florence Metge, Eric Denion, Pascal Dureau, Catherine Edelson, Georges Caputo.   

Abstract

PURPOSE: To correlate the final outcome with the initial presentation and treatment in Coats disease retinal detachment.
METHODS: The records of 15 patients with retinal detachment were evaluated retrospectively regarding the age at the time of diagnosis, initial presentation, methods of treatment, visual and anatomic results, and complications. Changes in vision and retinal status were noted and correlated with the different methods of treatment to propose a therapeutic strategy.
RESULTS: In 15 patients (15 eyes), with a mean follow-up of 28 months (range, 6 months to 7 years), Coats disease was diagnosed at a mean age of 3.4 years (range 3 months to 15 years). Primary management was laser photocoagulation in seven patients, cryotherapy in two, and vitreoretinal surgery in six. Additional treatment was necessary in nine patients of whom six had laser photocoagulation, one had cryotherapy, and two had vitreoretinal surgery. Visual stability was achieved in 12 cases. Anatomic improvement was achieved in 12 eyes (3 cases of phthisis bulbi). No enucleation was ultimately necessary.
CONCLUSIONS: Carefully selected treatment can improve almost each eye with Coats disease complicated by retinal detachment. Although visual outcome is poor, anatomic improvement or stability is the main goal of the management.

Entities:  

Mesh:

Year:  2008        PMID: 18317340     DOI: 10.1097/IAE.0b013e31816b3158

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  7 in total

Review 1.  Paediatric retinal detachment: a review.

Authors:  Raffaele Nuzzi; Carlo Lavia; Roberta Spinetta
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

2.  Pars plana vitrectomy for treatment of advanced Coats' disease--presentation of a modified surgical technique and long-term follow-up.

Authors:  Daniela Suesskind; Elke Altpeter; Merle Schrader; Karl U Bartz-Schmidt; Sabine Aisenbrey
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-12       Impact factor: 3.117

3.  Risk of Tractional Retinal Detachment Following Intravitreal Bevacizumab Along with Subretinal Fluid Drainage and Cryotherapy for Stage 3B Coats' Disease.

Authors:  Vishalakshi Bhat; Palmeera D'Souza; Parag K Shah; V Narendran
Journal:  Middle East Afr J Ophthalmol       Date:  2016 Apr-Jun

4.  Coats' Disease: Very Long-Term Outcome After Early Stage Conventional Treatment.

Authors:  Salvatore Perrone; Alberto Rossetti; Patrick Sportiello; Pierfrancesco Mirabelli; Pierangela Cimatti; Daniele Doro
Journal:  Open Ophthalmol J       Date:  2016-02-29

5.  Experience with Intravitreal Ranibizumab as an Adjunct to Ablation Therapy in Eyes with Exudative Coats' Disease.

Authors:  Mohamed Nowara; Yousef A Fouad; Ihab Abdel Aziz; Ahmed M Habib; Mariam Al-Feky; Hisham Hassan
Journal:  Clin Ophthalmol       Date:  2021-01-29

6.  Coats disease in female population: A comparison of clinical presentation and outcomes.

Authors:  Gwendoline Piquin; Thibaut Chapron; Youssef Abdelmassih; Gilles Martin; Catherine Edelson; Georges Caputo; Florence Metge
Journal:  Front Med (Lausanne)       Date:  2022-08-04

7.  Modified transscleral external drainage of subretinal fluid in high bullous exudative retinal detachment due to Coats' disease.

Authors:  Shachi Rohan Desai; Omar Abdel Dayem; Arindam Chakravarti; Sundaram Natarajan
Journal:  Oman J Ophthalmol       Date:  2018 May-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.